{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T12:16:39Z","timestamp":1778156199834,"version":"3.51.4"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T00:00:00Z","timestamp":1773446400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T00:00:00Z","timestamp":1773446400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1038\/s41409-026-02807-2","type":"journal-article","created":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T18:30:34Z","timestamp":1773513034000},"page":"529-536","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Relapse patterns focusing on central nervous system involvement after allogeneic hematopoietic cell transplantation in adult patients with acute lymphoblastic leukemia"],"prefix":"10.1038","volume":"61","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8465-2791","authenticated-orcid":false,"given":"Jong Hyuk","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1266-9353","authenticated-orcid":false,"given":"Jaehyun","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daehun","family":"Kwag","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gi June","family":"Min","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sung-Soo","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9810-2050","authenticated-orcid":false,"given":"Sung-Eun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4524-6616","authenticated-orcid":false,"given":"Byung-Sik","family":"Cho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ki-Seong","family":"Eom","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoo-Jin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4098-3366","authenticated-orcid":false,"given":"Hee-Je","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chang-Ki","family":"Min","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5429-4839","authenticated-orcid":false,"given":"Seok-Goo","family":"Cho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2145-9131","authenticated-orcid":false,"given":"Jae-Ho","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,14]]},"reference":[{"key":"2807_CR1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2022.282332","author":"C Orvain","year":"2023","unstructured":"Orvain C, Chantepie S, Thomas X, Escofrre-Barbe M, Huguet F, Desbrosses Y, et al. Impact of central nervous system involvement in adult patients with Philadelphia-negative acute lymphoblastic leukemia: a GRAALL-2005 study. Haematologica. 2023. https:\/\/doi.org\/10.3324\/haematol.2022.282332.","journal-title":"Haematologica"},{"key":"2807_CR2","doi-asserted-by":"publisher","first-page":"1784","DOI":"10.1182\/blood.V72.5.1784.1784","volume":"72","author":"HM Kantarjian","year":"1988","unstructured":"Kantarjian HM, Walters RS, Smith TL, Keating MJ, Barlogie B, McCredie KB, et al. Identification of risk groups for development of central nervous system leukemia in adults with acute lymphocytic leukemia. Blood. 1988;72:1784\u20139.","journal-title":"Blood"},{"key":"2807_CR3","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1002\/cncr.10265","volume":"94","author":"UR Surapaneni","year":"2002","unstructured":"Surapaneni UR, Cortes JE, Thomas D, O\u2019Brien S, Giles FJ, Koller C, et al. Central nervous system relapse in adults with acute lymphoblastic leukemia. Cancer. 2002;94:773\u20139.","journal-title":"Cancer"},{"key":"2807_CR4","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1182\/blood.2022017035","volume":"141","author":"NE Kopmar","year":"2023","unstructured":"Kopmar NE, Cassaday RD. How I prevent and treat central nervous system disease in adults with acute lymphoblastic leukemia. Blood. 2023;141:1379\u201388. https:\/\/doi.org\/10.1182\/blood.2022017035.","journal-title":"Blood"},{"key":"2807_CR5","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1016\/j.bbmt.2014.07.005","volume":"20","author":"A Hamdi","year":"2014","unstructured":"Hamdi A, Mawad R, Bassett R, di Stasi A, Ferro R, Afrough A, et al. Central nervous system relapse in adults with acute lymphoblastic leukemia after allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transpl. 2014;20:1767\u201371. https:\/\/doi.org\/10.1016\/j.bbmt.2014.07.005.","journal-title":"Biol Blood Marrow Transpl"},{"key":"2807_CR6","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1016\/j.bbmt.2008.07.002","volume":"14","author":"K Oshima","year":"2008","unstructured":"Oshima K, Kanda Y, Yamashita T, Takahashi S, Mori T, Nakaseko C, et al. Central nervous system relapse of leukemia after allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transpl. 2008;14:1100\u20137. https:\/\/doi.org\/10.1016\/j.bbmt.2008.07.002.","journal-title":"Biol Blood Marrow Transpl"},{"key":"2807_CR7","doi-asserted-by":"publisher","first-page":"2367","DOI":"10.1038\/leu.2012.164","volume":"26","author":"S Lee","year":"2012","unstructured":"Lee S, Kim DW, Cho BS, Yoon JH, Shin SH, Yahng SA, et al. Impact of minimal residual disease kinetics during imatinib-based treatment on transplantation outcome in Philadelphia chromosome-positive acute lymphoblastic leukemia. Leukemia. 2012;26:2367\u201374. https:\/\/doi.org\/10.1038\/leu.2012.164.","journal-title":"Leukemia"},{"key":"2807_CR8","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1002\/cncr.31874","volume":"125","author":"J-H Yoon","year":"2019","unstructured":"Yoon J-H, Min GJ, Park S-S, Jeon Y-W, Lee S-E, Cho B-S, et al. Minimal residual disease\u2013based long-term efficacy of reduced-intensity conditioning versus myeloablative conditioning for adult Philadelphia-positive acute lymphoblastic leukemia. Cancer. 2019;125:873\u201383. https:\/\/doi.org\/10.1002\/cncr.31874.","journal-title":"Cancer"},{"key":"2807_CR9","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1038\/s41409-020-01097-6","volume":"56","author":"JH Yoon","year":"2021","unstructured":"Yoon JH, Min GJ, Park SS, Park S, Lee SE, Cho BS, et al. Impact of donor type on long-term graft-versus-host disease-free\/relapse-free survival for adult acute lymphoblastic leukemia in first remission. Bone Marrow Transpl. 2021;56:828\u201340. https:\/\/doi.org\/10.1038\/s41409-020-01097-6.","journal-title":"Bone Marrow Transpl"},{"key":"2807_CR10","doi-asserted-by":"publisher","DOI":"10.1177\/20406207221076762","volume":"13","author":"JH Yoon","year":"2022","unstructured":"Yoon JH, Min GJ, Park SS, Park S, Lee SE, Cho BS, et al. Durable outcomes of double cord blood transplantation in adults with acute lymphoblastic leukemia: high-risk features for early and long-term mortality. Ther Adv Hematol. 2022;13:20406207221076762. https:\/\/doi.org\/10.1177\/20406207221076762.","journal-title":"Ther Adv Hematol"},{"key":"2807_CR11","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1038\/s41409-020-01097-6","volume":"56","author":"J-H Yoon","year":"2021","unstructured":"Yoon J-H, Min GJ, Park S-S, Park S, Lee S-E, Cho B-S, et al. Impact of donor type on long-term graft-versus-host disease-free\/relapse-free survival for adult acute lymphoblastic leukemia in first remission. Bone Marrow Transpl. 2021;56:828\u201340. https:\/\/doi.org\/10.1038\/s41409-020-01097-6.","journal-title":"Bone Marrow Transpl"},{"key":"2807_CR12","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/bmt.2012.244","volume":"48","author":"Y Kanda","year":"2013","unstructured":"Kanda Y. Investigation of the freely available easy-to-use software \u2018EZR\u2019 for medical statistics. Bone Marrow Transpl. 2013;48:452\u20138. https:\/\/doi.org\/10.1038\/bmt.2012.244.","journal-title":"Bone Marrow Transpl"},{"key":"2807_CR13","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/j.bbmt.2008.03.011","volume":"14","author":"PD Harker-Murray","year":"2008","unstructured":"Harker-Murray PD, Thomas AJ, Wagner JE, Weisdorf D, Luo X, DeFor TE, et al. Allogeneic hematopoietic cell transplantation in children with relapsed acute lymphoblastic leukemia isolated to the central nervous system. Biol Blood Marrow Transpl. 2008;14:685\u201392. https:\/\/doi.org\/10.1016\/j.bbmt.2008.03.011.","journal-title":"Biol Blood Marrow Transpl"},{"key":"2807_CR14","doi-asserted-by":"publisher","first-page":"2346","DOI":"10.3324\/haematol.2023.284858","volume":"109","author":"S Blum","year":"2024","unstructured":"Blum S, Chalandon Y, Labopin M, Finke J, Gedde-Dahl T, Othman TB, et al. Incidence and outcome of central nervous system relapse after hematopoietic stem cell transplantation in patients suffering from acute myeloid leukemia and acute lymphoblastic leukemia: a study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation. Haematologica. 2024;109:2346\u201350. https:\/\/doi.org\/10.3324\/haematol.2023.284858.","journal-title":"Haematologica"},{"key":"2807_CR15","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1182\/blood-2005-11-4666","volume":"108","author":"HM Lazarus","year":"2006","unstructured":"Lazarus HM, Richards SM, Chopra R, Litzow MR, Burnett AK, Wiernik PH, et al. Central nervous system involvement in adult acute lymphoblastic leukemia at diagnosis: results from the international ALL trial MRC UKALL XII\/ECOG E2993. Blood. 2006;108:465\u201372. https:\/\/doi.org\/10.1182\/blood-2005-11-4666.","journal-title":"Blood"},{"key":"2807_CR16","doi-asserted-by":"publisher","first-page":"4246","DOI":"10.1200\/JCO.24.00272","volume":"42","author":"H Kantarjian","year":"2024","unstructured":"Kantarjian H, Short NJ, Haddad FG, Jain N, Huang X, Montalban-Bravo G, et al. Results of the Simultaneous Combination of Ponatinib and Blinatumomab in Philadelphia Chromosome-Positive ALL. J Clin Oncol. 2024;42:4246\u201351. https:\/\/doi.org\/10.1200\/JCO.24.00272.","journal-title":"J Clin Oncol"},{"key":"2807_CR17","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s13045-025-01709-y","volume":"18","author":"NJ Short","year":"2025","unstructured":"Short NJ, Kantarjian H, Furudate K, Jain N, Ravandi F, Karrar O, et al. Molecular characterization and predictors of relapse in patients with Ph + ALL after frontline ponatinib and blinatumomab. J Hematol Oncol. 2025;18:55 https:\/\/doi.org\/10.1186\/s13045-025-01709-y.","journal-title":"J Hematol Oncol"},{"key":"2807_CR18","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/s41586-018-0342-5","volume":"560","author":"H Yao","year":"2018","unstructured":"Yao H, Price TT, Cantelli G, Ngo B, Warner MJ, Olivere L, et al. Leukaemia hijacks a neural mechanism to invade the central nervous system. Nature. 2018;560:55\u201360. https:\/\/doi.org\/10.1038\/s41586-018-0342-5.","journal-title":"Nature"},{"key":"2807_CR19","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1002\/ajh.26320","volume":"96","author":"BS Cho","year":"2021","unstructured":"Cho BS, Min GJ, Park SS, Yoon SY, Park S, Jeon YW, et al. Low-dose thymoglobulin for prevention of chronic graft-versus-host disease in transplantation from an HLA-matched sibling donor. Am J Hematol. 2021;96:1441\u20139. https:\/\/doi.org\/10.1002\/ajh.26320.","journal-title":"Am J Hematol"},{"key":"2807_CR20","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.ejca.2018.11.003","volume":"106","author":"S Giebel","year":"2019","unstructured":"Giebel S, Labopin M, Czerw T, Soci\u00e9 G, Blaise D, Ghavamzadeh A, et al. Impact of anti-thymocyte globulin on results of allogeneic peripheral blood stem cell transplantation for patients with Philadelphia-positive acute lymphoblastic leukaemia: An analysis by the Acute Leukemia Working Party of the EBMT. Eur J Cancer. 2019;106:212\u20139. https:\/\/doi.org\/10.1016\/j.ejca.2018.11.003.","journal-title":"Eur J Cancer"},{"key":"2807_CR21","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1182\/bloodadvances.2018025643","volume":"3","author":"M Wakamatsu","year":"2019","unstructured":"Wakamatsu M, Terakura S, Ohashi K, Fukuda T, Ozawa Y, Kanamori H, et al. Impacts of thymoglobulin in patients with acute leukemia in remission undergoing allogeneic HSCT from different donors. Blood Adv. 2019;3:105\u201315. https:\/\/doi.org\/10.1182\/bloodadvances.2018025643.","journal-title":"Blood Adv"},{"key":"2807_CR22","doi-asserted-by":"publisher","first-page":"771.e771","DOI":"10.1016\/j.jtct.2023.09.015","volume":"29","author":"F Yuan","year":"2023","unstructured":"Yuan F, Li G, Li M, Wei X, Fu Y. Haploidentical Cord Blood Transplantation with 8 mg\/kg Antithymocyte Globulin as Graft-versus-Host Disease Prophylaxis Compared to Haploidentical Transplantation with 10 mg\/kg Antithymocyte Globulin in the Treatment of Acute Leukemia. Transpl Cell Ther. 2023;29:771.e771\u2013771.e710. https:\/\/doi.org\/10.1016\/j.jtct.2023.09.015.","journal-title":"Transpl Cell Ther"},{"key":"2807_CR23","doi-asserted-by":"publisher","first-page":"39","DOI":"10.3324\/haematol.2019.231704","volume":"106","author":"MI Del Principe","year":"2021","unstructured":"Del Principe MI, Buzzatti E, Piciocchi A, Forghieri F, Bonifacio M, Lessi F, et al. Clinical significance of occult central nervous system disease in adult acute lymphoblastic leukemia. A multicenter report from the Campus ALL Network. Haematologica. 2021;106:39\u201345. https:\/\/doi.org\/10.3324\/haematol.2019.231704.","journal-title":"Haematologica"},{"key":"2807_CR24","doi-asserted-by":"publisher","first-page":"3264","DOI":"10.1080\/10428194.2021.1957872","volume":"62","author":"RD Cordova-Serrano","year":"2021","unstructured":"Cordova-Serrano RD, Almanza-Huante E, Fernandez-Sanchez E, Hernandez-Alcantara A, Espinosa-Bautista K. Central nervous system (CNS) involvement has an adverse impact on survival in newly diagnosed adult acute lymphoblastic leukemia (ALL) assessed by flow cytometry. Leuk Lymphoma. 2021;62:3264\u201370. https:\/\/doi.org\/10.1080\/10428194.2021.1957872.","journal-title":"Leuk Lymphoma"},{"key":"2807_CR25","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1111\/bjh.18537","volume":"200","author":"M Dargenio","year":"2023","unstructured":"Dargenio M, Bonifacio M, Chiaretti S, Vitale A, Fracchiolla NS, Papayannidis C, et al. Incidence, treatment and outcome of central nervous system relapse in adult acute lymphoblastic leukaemia patients treated front-line with paediatric-inspired regimens: A retrospective multicentre Campus ALL study. Br J Haematol. 2023;200:440\u201350. https:\/\/doi.org\/10.1111\/bjh.18537.","journal-title":"Br J Haematol"},{"key":"2807_CR26","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1002\/ajh.23407","volume":"88","author":"C Martinez-Laperche","year":"2013","unstructured":"Martinez-Laperche C, Gomez-Garcia AM, Lassaletta A, Moscardo C, Vivanco JL, Molina J, et al. Detection of occult cerebrospinal fluid involvement during maintenance therapy identifies a group of children with acute lymphoblastic leukemia at high risk for relapse. Am J Hematol. 2013;88:359\u201364. https:\/\/doi.org\/10.1002\/ajh.23407.","journal-title":"Am J Hematol"},{"key":"2807_CR27","doi-asserted-by":"publisher","first-page":"E11","DOI":"10.1002\/ajh.26622","volume":"98","author":"S Paul","year":"2023","unstructured":"Paul S, Kantarjian H, Sasaki K, Marx K, Jain N, Savoy JM, et al. Intrathecal prophylaxis with 12 versus 8 administrations reduces the incidence of central nervous system relapse in patients with newly diagnosed Philadelphia chromosome positive acute lymphoblastic leukemia. Am J Hematol. 2023;98:E11\u2013E14. https:\/\/doi.org\/10.1002\/ajh.26622.","journal-title":"Am J Hematol"},{"key":"2807_CR28","doi-asserted-by":"publisher","DOI":"10.1177\/15330338231165866","volume":"22","author":"Y Zhu","year":"2023","unstructured":"Zhu Y, Zhu Y, Miao L, Jia T, Mao J, Xue L, et al. Comparison of the Efficacy and Safety of Ponatinib and Dasatinib in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia With Central Nervous System Relapse: A Retrospective Study. Technol Cancer Res Treat. 2023;22:15330338231165866. https:\/\/doi.org\/10.1177\/15330338231165866.","journal-title":"Technol Cancer Res Treat"},{"key":"2807_CR29","doi-asserted-by":"publisher","first-page":"4249","DOI":"10.1182\/blood-2023-189632","volume":"142","author":"S Chiaretti","year":"2023","unstructured":"Chiaretti S, Leoncin M, Elia L, Piciocchi A, Matarazzo M, Di Trani M, et al. Comparison between Dasatinib-Blinatumomab Vs Ponatinib-Blinatumomab Chemo-Free Strategy for Newly Diagnosed Ph+ Acute Lymphoblastic Leukemia Patients. Preliminary Results of the Gimema ALLL2820 Trial. Blood. 2023;142:4249\u20134249. https:\/\/doi.org\/10.1182\/blood-2023-189632.","journal-title":"Blood"},{"key":"2807_CR30","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1182\/blood-2008-02-140665","volume":"112","author":"K Porkka","year":"2008","unstructured":"Porkka K, Koskenvesa P, Lundan T, Rimpilainen J, Mustjoki S, Smykla R, et al. Dasatinib crosses the blood-brain barrier and is an efficient therapy for central nervous system Philadelphia chromosome-positive leukemia. Blood. 2008;112:1005\u201312. https:\/\/doi.org\/10.1182\/blood-2008-02-140665.","journal-title":"Blood"},{"key":"2807_CR31","doi-asserted-by":"publisher","first-page":"1990","DOI":"10.1080\/10428194.2021.1894647","volume":"62","author":"K Ravi","year":"2021","unstructured":"Ravi K, Franson A, Homan MJ, Roberts H, Pai MP, Miklja Z, et al. Comparative pharmacokinetic analysis of the blood-brain barrier penetration of dasatinib and ponatinib in mice. Leuk Lymphoma. 2021;62:1990\u20134. https:\/\/doi.org\/10.1080\/10428194.2021.1894647.","journal-title":"Leuk Lymphoma"},{"key":"2807_CR32","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1200\/JCO.23.01075","volume":"42","author":"R Foa","year":"2024","unstructured":"Foa R, Bassan R, Elia L, Piciocchi A, Soddu S, Messina M, et al. Long-Term Results of the Dasatinib-Blinatumomab Protocol for Adult Philadelphia-Positive ALL. J Clin Oncol. 2024;42:881\u20135. https:\/\/doi.org\/10.1200\/JCO.23.01075.","journal-title":"J Clin Oncol"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41409-026-02807-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41409-026-02807-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41409-026-02807-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T11:50:27Z","timestamp":1778154627000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41409-026-02807-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,14]]},"references-count":32,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["2807"],"URL":"https:\/\/doi.org\/10.1038\/s41409-026-02807-2","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,14]]},"assertion":[{"value":"30 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 January 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 February 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 March 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study complied with the principles of the Declaration of Helsinki and was approved by the Data Review Board and Institutional Review Boards of participating institutions. The requirement for written informed consent was waived due to the retrospective nature of the study involving only de-identified data (KC25RISI0296).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}]}}